Family · Pharmaceutical analytical standards
Vilanterol
An ultra-long-acting beta-2 agonist that relaxes the airway muscles for 24 hours. Approved in 2013, it is used in chronic obstructive pulmonary disease (COPD) and asthma. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was approved in May 2013 not on its own but in a combination inhaler with a corticosteroid, fluticasone furoate; combinations with an antimuscarinic (umeclidinium) and with both followed later.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
